FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 327:1413-1419 November 12, 1992 Number 20 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

BACKGROUND. The morbidity from obstructive airways disease (asthma and chronic obstructive pulmonary disease) is considerable, and the mortality rate is rising in several countries. It has been hypothesized that long-term improvement in prognosis might result from vigorous bronchodilator or antiinflammatory therapy. METHODS. In a multicenter trial we compared three inhalation regimens in which a beta 2-agonist (terbutaline, 2000 micrograms daily) was combined with a corticosteroid (beclomethasone, 800 micrograms daily), an anticholinergic bronchodilator (ipratropium bromide, 160 micrograms daily), or placebo. Patients with airways hyperresponsiveness and obstruction who were 18 to 60 years old were followed for 2 1/2 years. RESULTS. Of the 274 patients enrolled, 56 percent had allergies. The mean forced expiratory volume in one second (FEV1) was 64 percent of the predicted value. The mean PC20 (the concentration of inhaled histamine causing a 20 percent decrease in FEV1, a measure of hyperresponsiveness) was 0.26 mg per milliliter. Withdrawal from the study, due mainly to pulmonary symptoms, was less frequent in the corticosteroid group (12 of 91 patients) than in the anticholinergic-drug group (45 of 92 patients) or the placebo group (44 of 91 patients; P < 0.001). The mean FEV1 (+/- SE) increased by 10.3 +/- 1.3 percent of the predicted value in the corticosteroid group within three months and remained stable thereafter, whereas it did not change in the other two groups (P < 0.001). The PC20 increased by 2.0 doubling concentrations in the corticosteroid group but did not change in the other groups (P < 0.001). In the corticosteroid group, patients who did not smoke, who had allergies, or who were less than 40 years old benefited more from their treatment than did those who smoked, did not have allergies, or were over 40, but all subgroups of the corticosteroid group had improvement as compared with the anticholinergic-drug or placebo group. CONCLUSIONS. The addition of an inhaled corticosteroid--but not an inhaled anticholinergic agent--to maintenance treatment with a beta 2-agonist (terbutaline) substantially reduced morbidity, hyperresponsiveness, and airways obstruction in patients with a spectrum of obstructive airways disease.

Source Information

Department of Pulmonology, University Hospital Groningen, The Netherlands.

This article has been cited by other articles:

• Zheng, J.-P., Yang, L., Wu, Y. M., Chen, P., Wen, Z. G., Huang, W.-J., Shi, Y., Wang, C.-Z., Huang, S.-G., Sun, T.-y., Wang, G.-F., Xiong, S.-D., Zhong, N.-S. (2007). The Efficacy and Safety of Combination Salmeterol (50 {micro}g)/Fluticasone Propionate (500 {micro}g) Inhalation Twice Daily Via Accuhaler in Chinese Patients With COPD. Chest 132: 1756-1763 [Abstract] [Full Text]  
• Simpkins, J., Divine, G., Wang, M., Holmboe, E., Pladevall, M., Williams, L. K. (2007). Improving Asthma Care Through Recertification: A Cluster Randomized Trial. Arch Intern Med 167: 2240-2248 [Abstract] [Full Text]  
• Dijkstra, A, Vonk, J M, Jongepier, H, Koppelman, G H, Schouten, J P, ten Hacken, N H T, Timens, W, Postma, D S (2006). Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex. Thorax 61: 105-110 [Abstract] [Full Text]  
• Donohue, J. F. (2005). Combination Therapy for Chronic Obstructive Pulmonary Disease: Clinical Aspects. Proc Am Thorac Soc 2: 272-281 [Abstract] [Full Text]  
• Decramer, M, Gosselink, R, Bartsch, P, Lofdahl, C-G, Vincken, W, Dekhuijzen, R, Vestbo, J, Pauwels, R, Naeije, R, Troosters, T (2005). Effect of treatments on the progression of COPD: report of a workshop held in Leuven, 11-12 March 2004. Thorax 60: 343-349 [Abstract] [Full Text]  
• Albers, M., Schermer, T., van den Boom, G., Akkermans, R., van Schayck, C., van Herwaarden, C., van Weel, C. (2004). Efficacy of Inhaled Steroids in Undiagnosed Subjects at High Risk for COPD: Results of the Detection, Intervention, and Monitoring of COPD and Asthma Program. Chest 126: 1815-1824 [Abstract] [Full Text]  
• Donohue, J. F., Ohar, J. A. (2004). Effects of Corticosteroids on Lung Function in Asthma and Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 1: 152-160 [Abstract] [Full Text]  
• Perng, D.-W., Huang, H.-Y., Chen, H.-M., Lee, Y.-C., Perng, R.-P. (2004). Characteristics of Airway Inflammation and Bronchodilator Reversibility in COPD: A Potential Guide to Treatment. Chest 126: 375-381 [Abstract] [Full Text]  
• Bleecker, E. R. (2004). Similarities and Differences in Asthma and COPD: The Dutch Hypothesis. Chest 126: 93S-95S [Full Text]  
• Larj, M. J., Bleecker, E. R. (2004). Therapeutic Responses in Asthma and COPD: Corticosteroids. Chest 126: 138S-149S [Abstract] [Full Text]  
• Highland, K. B. (2003). Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease. ANN INTERN MED 139: 864-865 [Full Text]  
• Ionescu, A.A., Schoon, E. (2003). Osteoporosis in chronic obstructive pulmonary disease. Eur Respir J 22: 64s-75s [Abstract] [Full Text]  
• Sutherland, E R, Allmers, H, Ayas, N T, Venn, A J, Martin, R J (2003). Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis. Thorax 58: 937-941 [Abstract] [Full Text]  
• Hanania, N. A., Darken, P., Horstman, D., Reisner, C., Lee, B., Davis, S., Shah, T. (2003). The Efficacy and Safety of Fluticasone Propionate (250 {micro}g)/Salmeterol (50 {micro}g) Combined in the Diskus Inhaler for the Treatment of COPD. Chest 124: 834-843 [Abstract] [Full Text]  
• (2003). The pharmacoepidemiology of COPD: Recent advances and methodological discussion. Eur Respir J 22: 1s-44s [Full Text]  
• Fabbri, L. M., Romagnoli, M., Corbetta, L., Casoni, G., Busljetic, K., Turato, G., Ligabue, G., Ciaccia, A., Saetta, M., Papi, A. (2003). Differences in Airway Inflammation in Patients with Fixed Airflow Obstruction Due to Asthma or Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 167: 418-424 [Abstract] [Full Text]  
• Koh, Y. Y., Lee, M. H., Sun, Y. H., Park, Y., Kim, C. K. (2002). Improvement in Bronchial Hyperresponsiveness with Inhaled Corticosteroids in Children with Asthma: Importance of Family History of Bronchial Hyperresponsiveness. Am. J. Respir. Crit. Care Med. 166: 340-345 [Abstract] [Full Text]  
• Sin, D. D., Man, S. F. P. (2002). Low-Dose Inhaled Corticosteroid Therapy and Risk of Emergency Department Visits for Asthma. Arch Intern Med 162: 1591-1595 [Abstract] [Full Text]  
• Douma, W. R., Kerstjens, H. A. M., de Gooijer, A., Overbeek, S. E., Koeter, G. H., Postma, D. S. (2002). Initial Improvements in Lung Function and Bronchial Hyperresponsiveness Are Maintained During 5 Years of Treatment With Inhaled Beclomethasone Dipropionate and Terbutaline. Chest 121: 151-157 [Abstract] [Full Text]  
• VAN DEN BOOM, G., RUTTEN-VAN MOLKEN, M. P. M. H., MOLEMA, J., TIRIMANNA, P. R. S., VAN WEEL, C., VAN SCHAYCK, C. P. (2001). The Cost Effectiveness of Early Treatment with Fluticasone Propionate 250 {micro}g Twice a Day in Subjects with Obstructive Airway Disease . Results of the DIMCA Program. Am. J. Respir. Crit. Care Med. 164: 2057-2066 [Abstract] [Full Text]  
• VISSER, M. J., POSTMA, D. S., ARENDS, L. R., DE VRIES, T. W., DUIVERMAN, E. J., BRAND, P. L. P. (2001). One-Year Treatment with Different Dosing Schedules of Fluticasone Propionate in Childhood Asthma . Effects on Hyperresponsiveness, Lung Function, and Height. Am. J. Respir. Crit. Care Med. 164: 2073-2077 [Abstract] [Full Text]  
• Wu, A. W., Young, Y., Skinner, E. A., Diette, G. B., Huber, M., Peres, A., Steinwachs, D. (2001). Quality of Care and Outcomes of Adults With Asthma Treated by Specialists and Generalists in Managed Care. Arch Intern Med 161: 2554-2560 [Abstract] [Full Text]  
• Van Den BERGE, M., KERSTJENS, H. A. M., MEIJER, R. J., DE REUS, D. M., KOETER, G. H., KAUFFMAN, H. F., POSTMA, D. S. (2001). Corticosteroid-induced Improvement in the PC20 of Adenosine Monophosphate Is More Closely Associated with Reduction in Airway Inflammation than Improvement in the PC20 of Methacholine. Am. J. Respir. Crit. Care Med. 164: 1127-1132 [Abstract] [Full Text]  
• ten BRINKE, A., ZWINDERMAN, A. H., STERK, P. J., RABE, K. F., BEL, E. H. (2001). Factors Associated with Persistent Airflow Limitation in Severe Asthma. Am. J. Respir. Crit. Care Med. 164: 744-748 [Abstract] [Full Text]  
• ten BRINKE, A., de LANGE, C., ZWINDERMAN, A. H., RABE, K. F., STERK, P. J., BEL, E. H. (2001). Sputum Induction in Severe Asthma by a Standardized Protocol . Predictors of Excessive Bronchoconstriction. Am. J. Respir. Crit. Care Med. 164: 749-753 [Abstract] [Full Text]  
• SIN, D. D., TU, J. V. (2001). Inhaled Corticosteroids and the Risk of Mortality and Readmission In Elderly Patients with Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 164: 580-584 [Abstract] [Full Text]  
• Calverley, P.M.A. (2001). Modern treatment of chronic obstructive pulmonary disease. Eur Respir J 18: 60S-66s [Abstract] [Full Text]  
• Van Den BERGE, M., MEIJER, R. J., KERSTJENS, H. A. M., de REUS, D. M., KOETER, G. H., KAUFFMAN, H. F., POSTMA, D. S. (2001). PC20 Adenosine 5'-Monophosphate Is More Closely Associated with Airway Inflammation in Asthma Than PC20 Methacholine. Am. J. Respir. Crit. Care Med. 163: 1546-1550 [Abstract] [Full Text]  
• Cloosterman, S. G. M., Bijl-Hofland, I. D., van Herwaarden, C. L. A., Akkermans, R. P., van den Elshout, F. J. J., Folgering, H. T. M., van Schayck, C. P. (2001). A Placebo-Controlled Clinical Trial of Regular Monotherapy With Short-Acting and Long-Acting {beta}2-Agonists in Allergic Asthmatic Patients. Chest 119: 1306-1315 [Abstract] [Full Text]  
• Peters, J. (2001). Review: inhaled corticosteroids alone appear to be as effective as oral corticosteroids after emergency department discharge for acute asthma. Evid. Based Med. 6: 45-45 [Full Text]  
• The Lung Health Study Research Group, (2000). Effect of Inhaled Triamcinolone on the Decline in Pulmonary Function in Chronic Obstructive Pulmonary Disease. NEJM 343: 1902-1909 [Abstract] [Full Text]  
• PAPI, A., ROMAGNOLI, M., BARALDO, S., BRACCIONI, F., GUZZINATI, I., SAETTA, M., CIACCIA, A., FABBRI, L. M. (2000). Partial Reversibility of Airflow Limitation and Increased Exhaled NO and Sputum Eosinophilia in Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 162: 1773-1777 [Abstract] [Full Text]  
• Taylor, D R, Hancox, R J (2000). Interactions between corticosteroids and beta agonists. Thorax 55: 595-602 [Full Text]  
• Mannino, D. M., Gagnon, R. C., Petty, T. L., Lydick, E. (2000). Obstructive Lung Disease and Low Lung Function in Adults in the United States: Data From the National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 160: 1683-1689 [Abstract] [Full Text]  
• Balbi, B., Majori, M., Bertacco, S., Convertino, G., Cuomo, A., Donner, C. F., Pesci, A. (2000). Inhaled Corticosteroids in Stable COPD Patients : Do They Have Effects on Cells and Molecular Mediators of Airway Inflammation?. Chest 117: 1633-1637 [Abstract] [Full Text]  
• BARNES, P. J. (2000). Inhaled Corticosteroids Are Not Beneficial in Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 161: 342-344 [Full Text]  
• (2000). The use of inhaled corticosteroids in adults with asthma. DTB 38: 5-8 [Abstract] [Full Text]  
• Diette, G. B., Wu, A. W., Skinner, E. A., Markson, L., Clark, R. D., McDonald, R. C., Healy, J. P. Jr, Huber, M., Steinwachs, D. M. (1999). Treatment Patterns Among Adult Patients With Asthma: Factors Associated With Overuse of Inhaled {beta}-Agonists and Underuse of Inhaled Corticosteroids. Arch Intern Med 159: 2697-2704 [Abstract] [Full Text]  
• GROL, M. H., GERRITSEN, J., VONK, J. M., SCHOUTEN, J. P., KOËTER, G. H., RIJCKEN, B., POSTMA, D. S. (1999). Risk Factors for Growth and Decline of Lung Function in Asthmatic Individuals up to Age 42 years . A 30-year Follow-up Study. Am. J. Respir. Crit. Care Med. 160: 1830-1837 [Abstract] [Full Text]  
• POSTMA, D. S., KERSTJENS, H. A. M. (1999). Are Inhaled Glucocorticosteroids Effective in Chronic Obstructive Pulmonary Disease?. Am. J. Respir. Crit. Care Med. 160: S66-71 [Abstract] [Full Text]  
• Pauwels, R. A., Lofdahl, C.-G., Laitinen, L. A., Schouten, J. P., Postma, D. S., Pride, N. B., Ohlsson, S. V., The European Respiratory Society Study on Chronic, (1999). Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking. NEJM 340: 1948-1953 [Abstract] [Full Text]  
• Cox, G., Whitehead, L., Dolovich, M., Jordana, M., Gauldie, J., Newhouse, M. T. (1999). A Randomized Controlled Trial on the Effect of Inhaled Corticosteroids on Airways Inflammation in Adult Cigarette Smokers. Chest 115: 1271-1277 [Abstract] [Full Text]  
• van Grunsven, P M, van Schayck, C P, Molema, J, Akkermans, R P, van Weel, C (1999). Effect of inhaled corticosteroids on bronchial responsiveness in patients with "corticosteroid naive" mild asthma: a meta-analysis. Thorax 54: 316-322 [Abstract] [Full Text]  
• Jatakanon, A., Kharitonov, S., Lim, S., Barnes, P. J (1999). Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma. Thorax 54: 108-114 [Abstract] [Full Text]  
• Anthonisen, N. R. (1999). Steroids in COPD : The Nearly Eternal Question. Chest 115: 3-4 [Full Text]  
• CALVERLEY, P M A (1999). Re-assessing the evidence about inhaled corticosteroids in chronic obstructive pulmonary disease. Thorax 54: 3-4 [Full Text]  
• van Grunsven, P M, van Schayck, C P, Derenne, J P, Kerstjens, H A M, Renkema, T E J, Postma, D S, Similowski, T, Akkermans, R P, Jong, P C M P.-d., Dekhuijzen, P N R, van Herwaarden, C L A, van Weel, C (1999). Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Thorax 54: 7-14 [Abstract] [Full Text]  
• Bourbeau, J., Rouleau, M. Y, Boucher, S. (1998). Randomised controlled trial of inhaled corticosteroids in patients with chronic obstructive pulmonary disease. Thorax 53: 477-482 [Abstract] [Full Text]  
• BARNES, P. J., PEDERSEN, S., BUSSE, W. W. (1998). Efficacy and Safety of Inhaled Corticosteroids . New Developments. Am. J. Respir. Crit. Care Med. 157: S1-53 [Full Text]  
• RUTGERS, S. R., KOETER, G. H., van der MARK, T. W., POSTMA, D. S. (1998). Short-term Treatment with Budesonide Does Not Improve Hyperresponsiveness to Adenosine 5'-Monophosphate in COPD. Am. J. Respir. Crit. Care Med. 157: 880-886 [Abstract] [Full Text]  
• Barnes, P. J. (1995). Inhaled Glucocorticoids for Asthma. NEJM 332: 868-875 [Full Text]  
• Weinberger, S. E. (1993). Recent Advances in Pulmonary Medicine- First of Two Parts. NEJM 328: 1389-1397 [Full Text]  
• Rogol, P. R., Hahn, D. L., Kerstjens, H. A.M., Brand, P. L.P., Postma, D. S. (1993). Bronchodilator Therapy with or without Inhaled Corticosteroid Therapy for Obstructive Airways Disease. NEJM 328: 1044-1045 [Full Text]  
• (1992). CHRONIC INHALED STEROIDS FOR OBSTRUCTIVE AIRWAYS DISEASE. JWatch General 1992: 1-1 [Full Text]